ESC Premium Access

State of the art in therapeutic modulation of the immune response in atherosclerosis

Congress Session

About the speaker

Professor Peter Libby

Brigham and Women's Hospital, Boston (United States of America)
31 presentations
4 followers

4 more presentations in this session

Nanoparticle-enabled RNAi in endothelial cells attenuates inflammation in atherosclerosis and acute myocardial infarction

Speaker: Doctor H. Sager (Munich, DE)

Thumbnail

STAT4 deficiency exacerbates atherosclerosis by promoting mobilization of myeloid cells, polarization of M1 macrophages and formation of foam cells

Speaker: Doctor L. Xu (Shanghai, CN)

Thumbnail

Bone marrow-specific Sirt6 deletion enhances atherosclerosis and foam cell formation via an increase in macrophage scavenger receptor 1 expression

Speaker: Miss T. Arsiwala (Zurich, CH)

Thumbnail

Future direction for research in therapeutic modulation of the immune response in atherosclerosis.

Speaker: Professor J. Nilsson (Malm?, SE)

Thumbnail

Access the full session

Therapeutic modulation of the immune response in atherosclerosis

Speakers: Professor P. Libby, Doctor H. Sager, Doctor L. Xu, Miss T. Arsiwala, Professor J. Nilsson
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk